15 results
8-K
EX-99.1
SYRA
Syra Health Corp - Ordinary Shares
9 May 24
Results of Operations and Financial Condition
5:17pm
)
For the Three Months Ended
March 31,
Net revenues
Cost of services
Gross profit
Operating expenses:
Salaries and benefits
Professional services
Research … and development expenses
Selling, general and administrative expenses
Depreciation
Total operating expenses
Operating loss
Other income (expense
DEF 14A
SYRA
Syra Health Corp - Ordinary Shares
24 Apr 24
Definitive proxy
5:01pm
as a member of our Board of Directors since October 2023. Dr. Reddy has over 20 years of leadership experience in both in research and development
8-K
EX-99.1
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Results of Operations and Financial Condition
4:30pm
Operating expenses:
Salaries and benefits
Professional services
Research and development expenses
Selling, general and administrative expenses
Depreciation
10-K
2023 FY
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
Professional fees
Research and development expenses
Selling, general and administrative expenses
Depreciation
Total operating expenses:
Operating loss … and Development Expenses
Research and Development expenses primarily consist of consulting expenses incurred to develop our technology-based solutions. We
8-K
EX-99.2
23nuoi1 3r
4 Oct 23
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4:45pm
8-K
3sf3ranv s7b94g0iplo
4 Oct 23
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4:45pm
8-K
EX-99.1
lxb c4npcj5g
4 Oct 23
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4:45pm
424B4
q6ag03y 58
3 Oct 23
Prospectus supplement with pricing info
6:10am
S-1/A
pkj2ybzc32a
12 Jun 23
IPO registration (amended)
9:05pm
S-1
uh5oc32
3 May 23
IPO registration
9:34pm
- Prev
- 1
- Next